Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of oxycodone on individuals taking an SSRI
2022-001824-13Phase 4Terminated
- Sponsor
- Leiden University Medical Center
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oxycodone in major depressive disorder (MDD) and hypopnea (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Ventilation at extrapolated end-tidal PCO2 of 55 mmHg (VE55) at 4 hours. Started Jul 2022; status: terminated.
02
Drugs
oxycodone
03
Conditions
major depressive disorder (MDD)hypopnea
Beyond the preview
Go deeper on 2022-001824-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-001824-13.